Cover Image
市場調查報告書

生技藥品市場:各產品(單株抗體,疫苗,細胞治療,重組的荷爾蒙/蛋白質,基因治療),各用途 - 全球產業分析,規模,佔有率,成長,趨勢,預測

Biologics Market (Product - Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, and Gene Therapy; Applications) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

出版商 Transparency Market Research 商品編碼 403732
出版日期 內容資訊 英文 179 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
生技藥品市場:各產品(單株抗體,疫苗,細胞治療,重組的荷爾蒙/蛋白質,基因治療),各用途 - 全球產業分析,規模,佔有率,成長,趨勢,預測 Biologics Market (Product - Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, and Gene Therapy; Applications) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024
出版日期: 2016年10月05日 內容資訊: 英文 179 Pages
簡介

本報告提供全球生技藥品市場相關調查,提供市場現狀與未來發展預測,各產品,各用途,各地區趨勢,並彙整加入此市場的主要企業簡介等資料。

第1章 序論

第2章 假設和調查方法

第3章 摘要整理

第4章 市場概要

  • 簡介
  • 概要
  • 市場機會地圖
  • 市場趨勢
    • 促進要素
    • 阻礙要素
  • 市場分析與預測
    • 波特五力分析
    • 供應鏈分析
    • 市場收益預測
  • 市場預測

第5章 各產品市場分析與預測

  • 簡介和定義
  • 主要調查結果與趨勢
  • 市場價值佔有率分析
  • 各產品市場價值預測
    • 單株抗體
    • 疫苗
    • 重組的荷爾蒙/蛋白質
    • 細胞治療,
    • 基因治療
    • 其他
  • 各產品市場魅力度

第6章 各用途市場分析

  • 簡介和定義
  • 主要調查結果與趨勢
  • 市場價值佔有率分析
  • 各用途市場價值預測
    • 腫瘤
    • 感染疾病
    • 免疫學
    • 自體免疫疾病
    • 其他
  • 各用途市場的魅力度

第7章 各地區市場分析

  • 主要調查結果
  • 全球成長方案
  • 各地區市場價值預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲
  • 各地區市場的魅力度

第8章 北美市場

第9章 歐洲市場

第10章 亞太地區市場

第11章 南美市場

第12章 中東·非洲市場

第13章 競爭環境

  • 主要企業:競爭儀表板
  • 重量級藥物矩陣
  • 主要的生物學的治療的開發平台(管線)概要
  • 企業簡介
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca
    • Bayer AG
    • Eli Lilly and Company
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline Plc.
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi

圖表

目錄

Title: Biologics Market (Product - Monoclonal Antibodies, Vaccines, Cell Therapy, Recombinant Hormones/Proteins, and Gene Therapy; Applications - Infectious Diseases, Oncology, Immunology, and Autoimmune Diseases) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.

Global Biologics Market: Scope and Methodology

This report provides forecast and analysis of the global biologics market on the global and regional levels. It provides historical data of 2015 along with forecast from 2016 to 2024 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook for biologics revenue annually. It includes drivers and restraints of the global biologics market and their impact on each region during the forecast period. The report also comprises the study of applications and opportunities for biologics manufacturers. It also includes a detailed analysis by product type and supply chain analysis with a list of suppliers and industry stakeholders at each node in the supply chain.

In order to provide users of this report with a comprehensive view of the market, we have included detailed competitiveness analysis, key blockbuster products, clinical pipeline analysis and company players with unique propositions. The dashboard provides a comprehensive comparison of biologics manufacturers on parameters such as revenue sales, ranking of global players, strategic consolidations, i.e. mergers & acquisitions, licensing activities, as well as R&D activities. The study encompasses market attractiveness analysis, product type, application type, and region.

Global Biologics Market: Segmentation

The report includes the revenue generated from sales of biologics in all regions and important countries in these regions. By product, the global biologics market has been segmented into monoclonal antibodies, vaccines, recombinant hormones/vaccines, cell therapy, gene therapy and other products. By application type, the market is segmented into oncology, infectious diseases, immunology, auto-immune diseases, and other diseases. Furthermore, the global market is sub-segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Market numbers have been estimated based on the annual global and regional sales of key companies; annual production and the revenue of local players is derived from regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The global biologics market has been analyzed based on expected demand. Prices considered for the calculation of revenue are regional average prices obtained through primary quotes from numerous regional biologics manufacturers, suppliers, and distributors. All key end users have been considered, and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been taken into consideration while assessing the market for various products manufactured in different regions. Top-down approach has been used to estimate the biologics market by regions. Market numbers for global product type and application segments have been derived using the bottom-up approach, which is cumulative of each region's demand. The company-level market share has been calculated on the basis of revenues reported by key manufacturers. The market has been forecast based on constant currency rates.

Several primary and secondary sources were consulted during the course of the study. Secondary sources include Factiva, World Bank, FDA, NCBI, Springer Journals, Google Books, Society Publications, Biotechnology Innovation Organization, Arthritis Foundation, British Society for Rheumatology and Hoover's, as well as company annual reports and publications.

Global Biologics Market: Competitive Landscape

The report provides detailed competitive and company profiles of key participants operating in the global market. Key players in the global biologics market include AbbVie Inc., Amgen Inc, AstraZeneca, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and Sanofi.

The market has been segmented as below:

Global Biologics Market - By Product

  • Monoclonal Antibodies
  • Vaccines
  • Recombinant Hormones/Proteins
  • Cell Therapy
  • Gene Therapy
  • Others

Global Biologics Market - By Applications

  • Oncology
  • Infectious Diseases
  • Immunology
  • Autoimmune Diseases
  • Others

Global Biologics Market - By Region

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Europe
    • Germany
    • UK
    • Italy
    • Spain
    • France
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • New Zealand
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • RSA
    • Rest of MEA

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Biologics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
  • 4.2. Overview
  • 4.3. Market Opportunity Map
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Biologics Market Analysis and Forecasts, 2014-2024
    • 4.5.1. Porter's Analysis
    • 4.5.2. Supply Chain Analysis
      • 4.5.2.1. Product Manufacturers
      • 4.5.2.2. Product Distributors
      • 4.5.2.3. End Users
    • 4.5.3. Market Revenue Projections (US$ Mn)
  • 4.9. Market Outlook

5. Global Biologics Market Analysis and Forecasts, By Product

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Global Biologics Market Value Share Analysis
  • 5.4. Market Value Forecast By Product , 2014-2024
    • 5.4.1. Monoclonal Antibodies
    • 5.4.2. Vaccines
    • 5.4.3. Recombinant Hormones/Proteins
    • 5.4.4. Cell Therapy
    • 5.4.5. Gene Therapy
    • 5.4.6. Others
  • 5.5. Market Attractiveness By Product

6. Global Biologics Market Analysis and Forecasts, By Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Global Biologics Market Value Share Analysis
  • 6.4. Market Value Forecast By Application , 2014-2024
    • 6.4.1. Oncology
    • 6.4.2. Infectious Diseases
    • 6.4.3. Immunology
    • 6.4.4. Autoimmune Diseases
    • 6.4.5. Others
  • 6.5. Market Attractiveness By Application

7. Global Biologics Market Analysis and Forecasts, By Region

  • 7.1. Key Findings
  • 7.2. Global Growth Scenario
  • 7.3. Market Value Forecast By Region
    • 7.3.1. North America
    • 7.3.2. Europe
    • 7.3.3. Asia Pacific
    • 7.3.4. Latin America
    • 7.3.5. MEA
  • 7.4. Market Attractiveness By Country/Region

8. North America Biologics Market Analysis and Forecast

  • 8.1. Introduction/ Key findings
  • 8.2. Market Value Forecast By Product , 2014-2024
    • 8.2.1. Monoclonal Antibodies
    • 8.2.2. Vaccines
    • 8.2.3. Recombinant Hormones/Proteins
    • 8.2.4. Cell Therapy
    • 8.2.5. Gene Therapy
    • 8.2.6. Others
  • 8.3. Market Value Forecast By Application , 2014-2024
    • 8.3.1. Oncology
    • 8.3.2. Infectious Diseases
    • 8.3.3. Immunology
    • 8.3.4. Autoimmune Diseases
    • 8.3.5. Others
  • 8.4. Market Value Forecast By Country , 2014-2024
    • 8.4.1. US
    • 8.4.2. Canada
  • 8.5. Market Attractiveness Analysis
    • 8.5.1. By Product
    • 8.5.2. By Application
    • 8.5.3. By Country

9. Europe Biologics Market Analysis and Forecast

  • 9.1. Introduction/Key Findings
  • 9.2. Market Value Forecast By Product , 2014-2024
    • 9.2.1. Monoclonal Antibodies
    • 9.2.2. Vaccines
    • 9.2.3. Recombinant Hormones/Proteins
    • 9.2.4. Cell Therapy
    • 9.2.5. Gene Therapy
    • 9.2.6. Others
  • 9.3. Market Value Forecast By Application , 2014-2024
    • 9.3.1. Oncology
    • 9.3.2. Infectious Diseases
    • 9.3.3. Immunology
    • 9.3.4. Autoimmune Diseases
    • 9.3.5. Others
  • 9.4. Market Value Forecast By Country , 2014-2024
    • 9.4.1. Germany
    • 9.4.2. UK
    • 9.4.3. Spain
    • 9.4.4. France
    • 9.4.5. Italy
    • 9.4.6. Rest of Europe
  • 9.5. Market Attractiveness Analysis
    • 9.5.1. By Product
    • 9.5.2. By Application
    • 9.5.3. By Country

10. Asia Pacific Biologics Market Analysis and Forecast

  • 10.1. Introduction/Key Findings
  • 10.2. Market Value Forecast By Product , 2014-2024
    • 10.2.1. Monoclonal Antibodies
    • 10.2.2. Vaccines
    • 10.2.3. Recombinant Hormones/Proteins
    • 10.2.4. Cell Therapy
    • 10.2.5. Gene Therapy
    • 10.2.6. Others
  • 10.3. Market Value Forecast By Application , 2014-2024
    • 10.3.1. Oncology
    • 10.3.2. Infectious Diseases
    • 10.3.3. Immunology
    • 10.3.4. Autoimmune Diseases
    • 10.3.5. Others
  • 10.4. Market Value Forecast By Country , 2014-2024
    • 10.4.1. India
    • 10.4.2. China
    • 10.4.3. Japan
    • 10.4.4. Australia
    • 10.4.5. New Zealand
    • 10.4.6. Rest of Asia Pacific
  • 10.5. Market Attractiveness Analysis
    • 10.5.1. By Product
    • 10.5.2. By Application
    • 10.5.3. By Country

11. Latin America Biologics Market Analysis and Forecast

  • 11.1. Introduction/Key Findings
  • 11.2. Market Value Forecast By Product , 2014-2024
    • 11.2.1. Monoclonal Antibodies
    • 11.2.2. Vaccines
    • 11.2.3. Recombinant Hormones/Proteins
    • 11.2.4. Cell Therapy
    • 11.2.5. Gene Therapy
    • 11.2.6. Others
  • 11.3. Market Value Forecast By Application , 2014-2024
    • 11.3.1. Oncology
    • 11.3.2. Infectious Diseases
    • 11.3.3. Immunology
    • 11.3.4. Autoimmune Diseases
    • 11.3.5. Others
  • 11.4. Market Value Forecast By Country , 2014-2024
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of LATAM
  • 11.5. Market Attractiveness Analysis
    • 11.5.1. By Product
    • 11.5.2. By Application
    • 11.5.3. By Country

12. MEA Biologics Market Analysis and Forecast

  • 12.1. Introduction/Key Findings
  • 12.2. Market Value Forecast By Product , 2014-2024
    • 12.2.1. Monoclonal Antibodies
    • 12.2.2. Vaccines
    • 12.2.3. Recombinant Hormones/Proteins
    • 12.2.4. Cell Therapy
    • 12.2.5. Gene Therapy
    • 12.2.6. Others
  • 12.3. Market Value Forecast By Application , 2014-2024
    • 12.3.1. Oncology
    • 12.3.2. Infectious Diseases
    • 12.3.3. Immunology
    • 12.3.4. Autoimmune Diseases
    • 12.3.5. Others
  • 12.4. Market Value Forecast By Country , 2014-2024
    • 12.4.1. South Africa
    • 12.4.2. Saudi Arabia
    • 12.4.3. UAE
    • 12.4.4. Rest of MEA
  • 12.5. Market Attractiveness Analysis
    • 12.5.1. By Product
    • 12.5.2. By Application
    • 12.5.3. By Country

13. Competition Landscape

  • 13.1. Market Player - Competition Dashboard (By Tier and Size of companies)
  • 13.2. Blockbuster Drug Matrix
  • 13.3. Pipeline snapshot of Key Biological Therapies
  • 13.4. Company Profiles
    • 13.4.1. AbbVie Inc.
      • 13.4.1.1. Company Overview
      • 13.4.1.2. Financials
      • 13.4.1.3. SWOT Analysis
      • 13.4.1.4. Strategic Overview
    • 13.4.2. Amgen Inc.
      • 13.4.2.1. Company Overview
      • 13.4.2.2. Financials
      • 13.4.2.3. SWOT Analysis
      • 13.4.2.4. Strategic Overview
    • 13.4.3. AstraZeneca
      • 13.4.3.1. Company Overview
      • 13.4.3.2. Financials
      • 13.4.3.3. SWOT Analysis
      • 13.4.3.4. Strategic Overview
    • 13.4.4. Bayer AG
      • 13.4.4.1. Company Overview
      • 13.4.4.2. Financials
      • 13.4.4.3. SWOT Analysis
      • 13.4.4.4. Strategic Overview
    • 13.4.5. Eli Lilly and Company
      • 13.4.5.1. Company Overview
      • 13.4.5.2. Financials
      • 13.4.5.3. SWOT Analysis
      • 13.4.5.4. Strategic Overview
    • 13.4.6. F. Hoffmann-La Roche Ltd.
      • 13.4.6.1. Company Overview
      • 13.4.6.2. Financials
      • 13.4.6.3. SWOT Analysis
      • 13.4.6.4. Strategic Overview
    • 13.4.7. GlaxoSmithKline Plc.
      • 13.4.7.1. Company Overview
      • 13.4.7.2. Financials
      • 13.4.7.3. SWOT Analysis
      • 13.4.7.4. Strategic Overview
    • 13.4.8. Johnson & Johnson Services, Inc.
      • 13.4.8.1. Company Overview
      • 13.4.8.2. Financials
      • 13.4.8.3. SWOT Analysis
      • 13.4.8.4. Strategic Overview
    • 13.4.9. Merck & Co., Inc.
      • 13.4.9.1. Company Overview
      • 13.4.9.2. Financials
      • 13.4.9.3. SWOT Analysis
      • 13.4.9.4. Strategic Overview
    • 13.4.10. Novartis AG
      • 13.4.10.1. Company Overview
      • 13.4.10.2. Financials
      • 13.4.10.3. SWOT Analysis
      • 13.4.10.4. Strategic Overview
    • 13.4.11. Pfizer Inc.
      • 13.4.11.1. Company Overview
      • 13.4.11.2. Financials
      • 13.4.11.3. SWOT Analysis
      • 13.4.11.4. Strategic Overview
    • 13.4.12. Sanofi
      • 13.4.12.1. Company Overview
      • 13.4.12.2. Financials
      • 13.4.12.3. SWOT Analysis
      • 13.4.12.4. Strategic Overview

List of Figures

  • Figure 01: Global Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 02: Global Biologics Market Absolute $ Opportunity (US$ Mn), 2016?2024
  • Figure 03: Global Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 04: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 05: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 06: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 07: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 08: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 09: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 10: Global Biologics Market Attractiveness Analysis: by Product
  • Figure 11: Global Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 12: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 13: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 14: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 15: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 16: Global Biologics Market Value (US$ Mn) and Y-o-Y Growth (%), 2016-2024
  • Figure 17: Global Biologics Market Attractiveness Analysis: by Applications
  • Figure 18: Global Biologics Market Value Share Analysis: by Region, 2016 and 2024
  • Figure 19: Global Biologics Market Attractiveness Analysis: by Region
  • Figure 20: North America Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 21: North America Biologics Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 22: North America Biologics Market Attractiveness Analysis: by Country
  • Figure 23: North America Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 24: North America Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 25: North America Biologics Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 26: U.S. Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 27: U.S. Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 28: Canada Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 29: Canada Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 30: North America Biologics Market Forecast: by Product, 2016-2024
  • Figure 31: North America Biologics Market Forecast: by Application, 2016-2024
  • Figure 32: Europe Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 33: Europe Biologics Y-o-Y Growth Projections, 2016-2024
  • Figure 34: Europe Market Attractiveness Analysis: by Country
  • Figure 35: Europe Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 36: Europe Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 37: Europe Biologics Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 38: Germany Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 39: Germany Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 40: U.K. Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 41: U.K. Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 42: France Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 43: France Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 44: Italy Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 45: Italy Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 46: Spain Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 47: Spain Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 48: Rest of Europe Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 49: Rest of Europe Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 50: Europe Biologics Market Forecast By Product Type, 2016-2024
  • Figure 51: Europe Biologics Market Forecast By Application, 2016-2024
  • Figure 52: Asia Pacific Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 53: Asia Pacific Biologics Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 54: Asia Pacific Biologics Market Attractiveness Analysis: by Country, 2016-2024
  • Figure 55: Asia Pacific Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 56: Asia Pacific Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 57: Asia Pacific Biologics Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 58: China Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 59: China Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 60: Japan Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 61: Japan Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 62: India Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 63: India Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 64: Australia Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 65: Australia Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 66: New Zealand Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 67: New Zealand Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 68: Rest of APAC Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 69: Rest of APAC Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 70: Asia Pacific Biologics Market Attractiveness Analysis: by Product, 2016-2024
  • Figure 71: Asia Pacific Biologics Market Attractiveness Analysis: by Applications, 2016-2024
  • Figure 72: Latin America Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 73: Latin America Biologics Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 74: Latin America Market Attractiveness Analysis: by Country
  • Figure 75: Latin America Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 76: Latin America Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 77: Latin America Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 78: Brazil Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 79: Brazil Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 80: Mexico Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 81: Mexico Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 82: Rest of LATAM Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 83: Rest of LATAM Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 84: Latin America Biologics Market Attractiveness Analysis: by Product, 2016-2024
  • Figure 85: Latin America Biologics Market Attractiveness Analysis: by Applications, 2016-2024
  • Figure 86: MEA Biologics Market Size (US$ Mn) and Volume (Units) Forecast, 2016-2024
  • Figure 87: MEA Biologics Market Size and Y-o-Y Growth Projections, 2016-2024
  • Figure 88: MEA Biologics Market Attractiveness Analysis: by Country
  • Figure 89: Middle East and Africa Biologics Market Value Share Analysis: by Product, 2016 and 2024
  • Figure 90: Middle East and Africa Biologics Market Value Share Analysis: by Applications, 2016 and 2024
  • Figure 91: MEA Biologics Market Value Share Analysis: by Country, 2016 and 2024
  • Figure 92: Saudi Arabia Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 93: Saudi Arabia Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 94: UAE Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 95: UAE Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 96: RSA Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 97: RSA Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 98: RSA Biologics Market Size (US$ Mn) Forecast, 2016-2024
  • Figure 99: RSA Biologics Market Absolute $ Opportunity (US$ Mn), 2016-2024
  • Figure 100: MEA Biologics Market Attractiveness Analysis: by Product, 2016-2024
  • Figure 101: MEA Biologics Market Attractiveness Analysis: by Applications, 2016-2024

List of Tables

  • Table 01: Global Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 02: Global Biologics Market Size (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 03: Global Biologics Market Size (US$ Mn) Forecast: by Region, 2016-2024
  • Table 04: North America Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 05: North America Biologics Market Size (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 06: North America Biologics Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 07: Europe Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 08: Europe Biologics Market Size (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 09: Europe Biologics Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 10: Asia Pacific Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 11: Asia Pacific Biologics Market Size (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 12: Asia Pacific Biologics Market Size (US$ Mn) Forecast: by Country, 2016-2024
  • Table 13: Latin America Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 14: Latin America Biologics Market Size (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 15: Latin America Biologics Market Size (US$ Mn) by Country, 2016-2024
  • Table 16: Middle East and Africa Biologics Market Size (US$ Mn) Forecast: by Product, 2016-2024
  • Table 17: Middle East and Africa Biologics Market Value (US$ Mn) Forecast: by Applications, 2016-2024
  • Table 18: Middle East & Africa Biologics Market Size (US$ Mn) Forecast: by Country, 2016-2024
Back to Top